Contineum Therapeutics, Inc. Class A Common Stock
CTNM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$42 | $23 | -$24 | -$29 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7 | $2 | $2 | $2 |
| Change in WC | $5 | -$1 | -$1 | $0 |
| Other Non-Cash | -$3 | -$5 | $3 | $1 |
| Operating Cash Flow | -$33 | $19 | -$20 | -$26 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$226 | -$142 | -$65 | -$67 |
| Inv. Sales/Matur. | $157 | $77 | $87 | $2 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$70 | -$66 | $22 | -$65 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$4 | -$1 | $0 |
| Stock Issued | $108 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $60 | $0 | $80 |
| Financing Cash Flow | $109 | $56 | -$1 | $80 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $6 | $10 | $1 | -$11 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16 | $6 | $5 | $16 |
| End Cash | $22 | $16 | $6 | $5 |
| Free Cash Flow | -$33 | $19 | -$20 | -$26 |